• Strategy

    The Global Fund Strategy 2012-2016: Investing for Impact is an ambitious framework to transform the Global Fund into the most effective vehicle for investing in impact on the three diseases. The strategy commits the organization to a program of transformation and also outlines how the organization intends to work with countries and partners in order to sustain and accelerate existing gains and contribute to ambitious international goals.

    The Global Fund aspires to contribute substantially to international goals by saving 10 million lives and preventing 140-180 million new infections from HIV/AIDS, TB and malaria between 2012 and 2016. These goals are complemented by disease-specific targets aligned with the global targets set by UNAIDS, the World Health Organization, and the Stop TB and Roll Back Malaria partnerships.

    To achieve this, the Global Fund will “invest for impact”, based on five strategic objectives:

    1. Invest more strategically in areas with high potential for impact and strong value for money, and fund based on countries’ national strategies;
    2. Evolve the funding model to provide funding in a more proactive, flexible, predictable and effective way;
    3. Actively support grant implementation success through more active grant management and better engagement with partners;
    4. Promote and protect human rights in the context of the three diseases; and
    5. Sustain the gains, mobilize resources – by increasing the sustainability of supported programs and attracting additional funding from current and new sources.

    For a copy of the Strategic Framework of the strategy, please click here

    The implementation of the funding model is a key element of this strategy. For more information on the funding model, please click here.

    The Global Fund Strategy 2012-2016

    was approved by the Board in November 2011, and was the result of a process of thorough engagement and consultation with a diverse group of stakeholders. The Technical Evaluation and Reference Group, an independent body of experts, will be conducting a mid-term review of the strategy and its implementation during the course of 2014.